Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Role of BNP levels on the prognosis of decompensated advanced heart failure.

Pereira-Barretto AC, Carlo CH, Cardoso JN, Ochiai ME, Lima MV, Curiati MC, Scipioni AR, Ramires JA.

Arq Bras Cardiol. 2013 Mar;100(3):281-7. English, Portuguese.

3.

B-type natriuretic peptide levels in obese patients with advanced heart failure.

Horwich TB, Hamilton MA, Fonarow GC.

J Am Coll Cardiol. 2006 Jan 3;47(1):85-90. Epub 2005 Dec 15.

4.

Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure.

Fonarow GC, Peacock WF, Phillips CO, Givertz MM, Lopatin M; ADHERE Scientific Advisory Committee and Investigators.

J Am Coll Cardiol. 2007 May 15;49(19):1943-50. Epub 2007 Apr 30.

5.

B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction.

van Veldhuisen DJ, Linssen GC, Jaarsma T, van Gilst WH, Hoes AW, Tijssen JG, Paulus WJ, Voors AA, Hillege HL.

J Am Coll Cardiol. 2013 Apr 9;61(14):1498-506. doi: 10.1016/j.jacc.2012.12.044.

6.

Prognostic utility of B-type natriuretic peptide assessment in stable low-risk outpatients with nonischemic cardiomyopathy after decompensated heart failure.

Nishii M, Inomata T, Takehana H, Naruke T, Yanagisawa T, Moriguchi M, Takeda S, Izumi T.

J Am Coll Cardiol. 2008 Jun 17;51(24):2329-35. doi: 10.1016/j.jacc.2007.11.085.

7.

BNP at discharge in acute heart failure patients: is it all about volemia? A study using impedance cardiography to assess fluid and hemodynamic status.

Pimenta J, Paulo C, Mascarenhas J, Gomes A, Azevedo A, Rocha-Gonçalves F, Bettencourt P.

Int J Cardiol. 2010 Nov 19;145(2):209-14. doi: 10.1016/j.ijcard.2009.08.001. Epub 2009 Sep 3.

PMID:
19729213
8.

Impact of history of heart failure on diagnostic and prognostic value of BNP: results from the B-type Natriuretic Peptide for Acute Shortness of Breath Evaluation (BASEL) study.

Boldanova T, Noveanu M, Breidthardt T, Potocki M, Reichlin T, Taegtmeyer A, Christ M, Laule K, Stelzig C, Mueller C.

Int J Cardiol. 2010 Jul 23;142(3):265-72. doi: 10.1016/j.ijcard.2008.12.214. Epub 2009 Jan 29.

PMID:
19185372
9.

Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.

Neuhold S, Huelsmann M, Strunk G, Stoiser B, Struck J, Morgenthaler NG, Bergmann A, Moertl D, Berger R, Pacher R.

J Am Coll Cardiol. 2008 Jul 22;52(4):266-72. doi: 10.1016/j.jacc.2008.03.050.

10.

How often we need to measure brain natriuretic peptide (BNP) blood levels in patients admitted to the hospital for acute severe heart failure? Role of serial measurements to improve short-term prognostic stratification.

Faggiano P, Valle R, Aspromonte N, D'Aloia A, Di Tano G, Barro S, Giovinazzo P, Milani L, Lorusso R, Dei Cas L.

Int J Cardiol. 2010 Apr 1;140(1):88-94. doi: 10.1016/j.ijcard.2008.11.020. Epub 2009 Mar 24.

PMID:
19321212
11.

Combination of B-type natriuretic peptide and peak oxygen consumption improves risk stratification in outpatients with chronic heart failure.

Isnard R, Pousset F, Chafirovskaïa O, Carayon A, Hulot JS, Thomas D, Komajda M.

Am Heart J. 2003 Oct;146(4):729-35.

PMID:
14564330
12.

Comparison of the prognostic usefulness of N-terminal pro-brain natriuretic Peptide in patients with heart failure with versus without chronic kidney disease.

Bruch C, Fischer C, Sindermann J, Stypmann J, Breithardt G, Gradaus R.

Am J Cardiol. 2008 Aug 15;102(4):469-74. doi: 10.1016/j.amjcard.2008.03.082. Epub 2008 May 24.

PMID:
18678308
13.

Comparison of usefulness of each of five predictors of mortality and urgent transplantation in patients with advanced heart failure.

Sachdeva A, Horwich TB, Fonarow GC.

Am J Cardiol. 2010 Sep 15;106(6):830-5. doi: 10.1016/j.amjcard.2010.04.045. Epub 2010 Aug 1.

PMID:
20816124
14.

B-type natriuretic peptide can predict the medium-term risk in patients with acute heart failure and preserved systolic function.

Valle R, Aspromonte N, Feola M, Milli M, Canali C, Giovinazzo P, Carbonieri E, Ceci V, Cerisano S, Barro S, Milani L.

J Card Fail. 2005 Sep;11(7):498-503.

PMID:
16198244
15.

Baseline and 6-month B-type natriuretic peptide changes are independent predictors of events in patients with advanced heart failure awaiting cardiac transplantation.

Campana C, Pasotti M, Klersy C, Alessandrino G, Albertini R, Magrini G, Ghio S, Tavazzi L.

J Cardiovasc Med (Hagerstown). 2009 Sep;10(9):671-6. doi: 10.2459/JCM.0b013e328329346a.

PMID:
19444135
16.

Reduction in BNP levels with treatment of decompensated heart failure and future clinical events.

Dhaliwal AS, Deswal A, Pritchett A, Aguilar D, Kar B, Souchek J, Bozkurt B.

J Card Fail. 2009 May;15(4):293-9. doi: 10.1016/j.cardfail.2008.11.007. Epub 2008 Dec 23.

PMID:
19398076
17.

Plasma brain natriuretic peptide predicts short-term clinical outcome in heart failure patients with restrictive filling pattern.

Feola M, Aspromonte N, Milani L, Bobbio M, Bardellotto S, Barro S, Giovinazzo P, Noventa F, Valle R.

J Card Fail. 2008 Jun;14(5):420-5. doi: 10.1016/j.cardfail.2008.01.013. Epub 2008 May 27.

PMID:
18514935
18.
19.
20.

Natriuretic peptide system is not exhausted in severe heart failure.

Lourenço P, Azevedo A, Araújo JP, Bettencourt P.

J Cardiovasc Med (Hagerstown). 2009 Jan;10(1):39-43.

PMID:
19708225

Supplemental Content

Support Center